Lisa Almén is a strategy professional with over 15 years of experience in the pharmaceutical, consultancy, and venture capital industries. Currently serving as Gene Therapy and Haemophilia Lead for the FIND cluster at Pfizer Rare Diseases, they have spent the last decade in various commercial roles at Pfizer, focusing on rare diseases and gene therapy. Lisa has demonstrated a strong capability in leading cross-functional teams and developing strategic initiatives that drive business growth. Additionally, they actively influence the healthcare sector as deputy chair of the Danish Pharma Association's committee on rare diseases and advanced therapy medicinal products. Lisa is a co-author of the first policy paper for ATMPs in Denmark, highlighting their commitment to innovative therapies in healthcare.
This person is not in the org chart
This person is not in any teams
This person is not in any offices